CRN Announces New Clinical Research Site

The Clinical Research Network of the ACTSI is pleased to announce another new clinical research site, the Winship Cancer Institute Developmental Therapeutics Unit (DTU). The DTU focuses on the integration of translational science and patient care for those receiving novel antineoplastic agents specifically in phase I clinical trials that require close subject monitoring and blood sampling for pharmacokinetic and pharmacodynamic modeling.

Donald Harvey, PharmD serves as the director of the DTU and will join the CRN program director leadership team. CRN support for the DTU expands nursing, phlebotomy and sample processing and storage services to ACTSI investigators. If you are a clinical investigator and would like to utilize the DTU through a CRN supported mechanism, please visit the ACTSI website, and follow the protocol submission instructions. If you have questions, please contact Dr. Harvey (404-778-4381 or rdharve@emory.edu) or Debora Clem, CRN Program Manager (404-712-1993 or dclem@emory.edu).

Upcoming Events

View All Events

Latest News

Training

ACTSI-supported OculoStaple Wins Again

Atlanta Clinical & Translational Science Institute (ACTSI)-supported team, OculoStaple wins second place in the 2015 InVenture Prize at Georgia Tech. Team members Jackie Borinski, Mohamad Ali Najia, and Drew Padilla, all biomedical...

Discovery

Infographic: What are the Phases of Clinical Trials?